🇺🇸 FDA
Pipeline program

Bupivacaine

UW 14-345

Approved small_molecule completed

Quick answer

Bupivacaine for Pain is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Pain
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials